Last reviewed · How we verify

NCT03631524: IsoRehab2018

Using Telerehabilitation Tools to Deliver Quality Therapy to Patients Under Infective Isolation Precautions

Status unknown NA Last updated 9 November 2018
What this trial tests

NA trial testing Telerehabilitation in Deconditioning, Isolation Precautions in 60 participants. Status unknown.

Timeline
15 November 2018
Primary endpoint
20 December 2019
20 December 2019

Quick facts

Lead sponsorSingapore General Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment60
Start date15 November 2018
Primary completion20 December 2019
Estimated completion20 December 2019

Drugs / interventions tested

Conditions studied

Sponsor

Singapore General Hospital

Who can join

Adults 21 to 99, any sex, with Deconditioning, Isolation Precautions. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Single blinded Randomised Controlled trial comparing standard therapy to the intervention of up to 1 hour of physiotherapist-prescribed resistive training exercises administered via a telerehabilitation device per day in addition to standard therapy for a total of 10 sessions over a 2 week period. Total recruitment: 60 patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Telerehabilitation

Trials testing the same drug.

Other Singapore General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03631524.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing